Eisai Innovation Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
18
- Portfolio
-
15
- Exits
-
5
Eisai Innovation General Information
Company Description
Founded in 2019, Eisai Innovation is a corporate venture capital arm of Eisai based in Cambridge, Massachusetts. The firm seeks to invest in the neurology, oncology, diagnostics, digital health, and biotech sectors.
Business Details
Website
www.eisaiinnovation.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 1 Broadway
- 14th Floor
- Cambridge, MA 02142
- United States
Eisai Innovation Investments (18)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| VIVACTA Biotechnology | 13-Apr-2026 | Early Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Aikelian Biotechnology | 18-Mar-2026 | Biotechnology | Startup | |||
| Sift Bio | 18-Feb-2026 | Drug Discovery | Startup | |||
| Oura | 14-Oct-2025 | Therapeutic Devices | Profitable | |||
| ProTgen (Drug Discovery) | 02-Dec-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Hyku Biosciences | 12-Nov-2024 | Drug Discovery | Generating Revenue | |||
| Egenesis | 04-Sep-2024 | Drug Discovery | Clinical Trials - General | |||
| Iambic | 18-Jun-2024 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Ophidion | 24-May-2023 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| Tacit Therapeutics | 01-Mar-2023 | Early Stage VC | Drug Discovery | Generating Revenue |
Eisai Innovation Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Iambic | 15-Oct-2026 | IPO | |
| PRISM BioLab | 02-Jul-2024 | ||
| Caraway Therapeutics | 20-Nov-2023 | Merger/Acquisition | |
| Voluntis | 01-Nov-2021 | Merger/Acquisition |
Eisai Innovation Investments by Industry, Year, and Region
Eisai Innovation Co-Investors (70)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Apricot Capital (Shanghai) | 2 |
|
|
||
| b2venture |
|
|
|||
| ARCH Venture Partners |
|
|
|||
| Farallon Capital Management |
|
|
|||
| HBM Healthcare Investments |
|
|
Eisai Innovation FAQs
-
What is Eisai Innovation?
Founded in 2019, Eisai Innovation is a corporate venture capital arm of Eisai based in Cambridge, Massachusetts.
-
When was Eisai Innovation founded?
Eisai Innovation was founded in 2019.
-
Where is Eisai Innovation headquartered?
Eisai Innovation is headquartered in Cambridge, MA.
-
What is Eisai Innovation's total asset value?
Eisai Innovation has around in total assets under management.
-
How many investments has Eisai Innovation made?
Eisai Innovation has made 18 investments.
-
What has Eisai Innovation invested in?
Eisai Innovation has made numerous investments in companies like VIVACTA Biotechnology, Aikelian Biotechnology, and Sift Bio within the Drug Discovery and Biotechnology industries.
-
What has Eisai Innovation invested in recently?
Eisai Innovation's latest investment was on 13-Apr-2026 in VIVACTA Biotechnology, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process